In addition, previous studies have demonstrated that essential nodes in crucial pathways may be specifically blocked to slow glioma progression, which further suggests that MCM3 may be a promising therapeutic target for LGG (Tang et al., 2014; Liu et al., 2023). Here, MCM3 is linked to glioma.